Abstract 5258: Preclinical testing of CD73 inhibitor AB680 for pancreatic cancer immunoprevention
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-5258
Abstract: Introduction: Pancreatic ductal adenocarcinoma (PDAC) is characterized by a profoundly immunosuppressive microenvironment. Innovative therapeutic strategies are urgently needed to stop the progression of precancerous lesions into aggressive PDAC, which remains a lethal malignancy. The goal… read more here.
Keywords: ab680 treated; treated mice; pdac; cd73 inhibitor ... See more keywords